ALDO-DHF & Paramount

Por ElGuindy, Ahmed M
Publicado em 2013

TOPCAT misses its primary endpoint: Should spironolactone be abandoned in HFpEF?

Por ElGuindy, Ahmed M.
Publicado em 2013

HEAT-PPCI: A clear and welcome win for heparin

Por ElGuindy, Ahmed M.
Publicado em 2014

STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era

Por ElGuindy, Ahmed M.
Publicado no Glob Cardiol Sci Pract (2014)

STREAM at one year: Further evidence supporting a pharmacoinvasive strategy in patients with STEMI

Por ElGuindy, Ahmed M.
Publicado no Glob Cardiol Sci Pract (2015)

FAME 2: Reshaping the approach to patients with stable coronary artery disease

Por ElGuindy, Ahmed M.
Publicado no Glob Cardiol Sci Pract (2015)

PCI versus CABG in patients with complex coronary artery disease: Time for reconciliation?

Por ElGuindy, Ahmed M, Afifi, Ahmed
Publicado em 2013

FAME 2 – The best initial strategy for patients with stable coronary artery disease: Do we have an answer at last?

Por ElGuindy, Ahmed M, Bonow, Robert O
Publicado em 2013

BLOCK-HF: CRT gains new ground

Por ElGuindy, Ahmed M., ElMaghawry, Mohamed
Publicado em 2013

PARADIGM-HF: Have we achieved a new paradigm in the treatment of heart failure?

Por Bonow, Robert O., ElGuindy, Ahmed M.
Publicado no Glob Cardiol Sci Pract (2014)

NaNog: A pluripotency homeobox (master) molecule

Por Allouba, Mona H., ElGuindy, Ahmed M., Krishnamoorthy, Navaneethakrishnan, Yacoub, Magdi H., Aguib, Yasmine E.
Publicado no Glob Cardiol Sci Pract (2015)